Lam Research Corporation $LRCX Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC

Key Points

• UBS Asset Management has reduced its stake in Lam Research Corporation by 1.4%, selling 194,638 shares, and now owns approximately 1.05% of the company's stock, valued at about $972.73 million.
• A number of major analysts have raised their price targets for Lam Research, with Cantor Fitzgerald and Mizuho both increasing their targets to $120.00 and maintaining an "overweight" or "outperform" rating.
• Lam Research recently increased its quarterly dividend from $0.23 to $0.26, reflecting its strong performance, which includes a 33.6% year-over-year revenue growth during the most recent quarter.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 1.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 13,380,053 shares of the semiconductor company's stock after selling 194,638 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 1.05% of Lam Research worth $972,730,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock valued at $9,389,358,000 after purchasing an additional 8,364,375 shares during the last quarter. Nuveen LLC acquired a new position in shares of Lam Research in the 1st quarter valued at $604,344,000. Nuveen Asset Management LLC grew its stake in shares of Lam Research by 417.5% during the 4th quarter. Nuveen Asset Management LLC now owns 6,317,540 shares of the semiconductor company's stock valued at $456,316,000 after buying an additional 5,096,751 shares during the period. Rafferty Asset Management LLC increased its holdings in shares of Lam Research by 803.8% during the 4th quarter. Rafferty Asset Management LLC now owns 4,391,132 shares of the semiconductor company's stock worth $317,171,000 after buying an additional 3,905,272 shares during the last quarter. Finally, Two Sigma Advisers LP raised its position in shares of Lam Research by 1,036.4% in the 4th quarter. Two Sigma Advisers LP now owns 3,885,300 shares of the semiconductor company's stock worth $280,635,000 after buying an additional 3,543,400 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Up 1.2%

Shares of NASDAQ LRCX traded up $1.38 during midday trading on Friday, reaching $116.96. 11,054,667 shares of the company's stock were exchanged, compared to its average volume of 11,901,450. The stock has a market capitalization of $148.03 billion, a PE ratio of 28.12, a price-to-earnings-growth ratio of 1.38 and a beta of 1.76. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $117.50. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The business's fifty day moving average price is $100.71 and its two-hundred day moving average price is $86.43.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion during the quarter, compared to analyst estimates of $4.99 billion. During the same quarter last year, the firm earned $1.03 EPS. Lam Research's quarterly revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 annualized dividend and a dividend yield of 0.9%. This is an increase from Lam Research's previous quarterly dividend of $0.23. Lam Research's dividend payout ratio is currently 25.00%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Needham & Company LLC boosted their target price on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Barclays set a $83.00 target price on shares of Lam Research and gave the company an "equal weight" rating in a research note on Monday, July 28th. B. Riley reaffirmed a "buy" rating and set a $115.00 price target (up from $95.00) on shares of Lam Research in a research report on Wednesday, June 18th. Wells Fargo & Company set a $98.00 price objective on Lam Research and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Finally, Cantor Fitzgerald upped their target price on Lam Research from $115.00 to $120.00 and gave the stock an "overweight" rating in a research report on Thursday, August 21st. Twenty research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Lam Research has an average rating of "Moderate Buy" and an average target price of $107.96.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.